Company News in the Life Science Industry

»

Reset 

Veloxis Pharmaceuticals: Asahi Kasei Pharma Denmark Announces the Preliminary Result and Completion of its Public Tender Offer for the Shares and Warrants in Veloxis Pharmaceuticals

Read more ››
By: GlobenewsWire - 15 Jan 2020
Related companies:  Veloxis Pharmaceuticals A/S

Brian Loar appointed President C-RAD North America

Read more ››
By: GlobenewsWire - 15 Jan 2020
Related companies:  C-RAD AB

Dermavant Enters into Exclusive License Agreement with JT for Development and Commercialization of Tapinarof in Japan

Read more ››
By: GlobenewsWire - 15 Jan 2020
Related companies:  Dermavant Sciences GmbH

Athersys Names Ivor Macleod Chief Financial Officer

Read more ››
By: GlobenewsWire - 15 Jan 2020
Related companies:  Athersys, Inc.

Mesoblast Presents Commercial Plans at 2020 Biotech Showcase in San Francisco

Read more ››
By: GlobenewsWire - 15 Jan 2020
Related companies:  Mesoblast Limited

Call for Application for 2020 Tsinghua Amgen Scholars Program

BEIJING, Jan. 15, 2020 /PRNewswire/ -- The Amgen Scholars Program (ASP) is an international program funded by the Amgen Foundation with the direction of Harvard University, aiming to increase research opportunities for students committed to pursuing careers in the field of biomedical science.... Read more ››

By: PR Newswire Association LLC. - 15 Jan 2020
Related companies:  Tsinghua Yuanxing Biopharmaceutical Technology Co., Ltd. | School of Environment (SOE) of Tsinghua University (THU)

China's HEDY Group Acquires 10 Elekta Cancer Treatment Systems

GUANGZHOU, China, Jan. 15, 2020 /PRNewswire/ -- Elekta (EKTA-B.ST) and HEDY Group of Guangzhou, China, recently signed an agreement for 10 linear accelerators (linacs) as well as Monaco(®) treatment planning, MOSAIQ(®) Oncology Information System and service for each of the linacs.

Read more ››
By: PR Newswire Association LLC. - 15 Jan 2020
Related companies:  ELEKTA AB

Medscape's 2020 Physician Burnout Report Finds Main Causes and Coping Mechanisms Differ by Generation

NEW YORK, Jan. 15, 2020 /PRNewswire/ -- The issue of burnout and depression continues to have a significant impact on physicians' personal and professional lives, and Generation X physicians are more likely to experience it than their older and younger colleagues, according to the results of... Read more ››

By: PR Newswire Association LLC. - 15 Jan 2020
Related companies:  Medscape Education, Medscape, LLC

IDEAYA Biosciences Announces Synthetic Lethality Research Highlights and Target Milestones for 2020

SOUTH SAN FRANCISCO, Calif., Jan. 15, 2020 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ:IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics to treat cancer, announced key research highlights from its synthetic lethality... Read more ››

By: PR Newswire Association LLC. - 15 Jan 2020
Related companies:  IDEAYA Biosciences, Inc.

Bioz Stars Awards - 2019 - Recognizing the World's Most Innovative Suppliers of Life Science Reagents, Kits, Instruments and Tools

LOS ALTOS, Calif., Jan. 15, 2020 /PRNewswire/ -- Bioz, Inc., a Silicon Valley AI data company for life science research, is excited to announce... Read more ››

By: PR Newswire Association LLC. - 15 Jan 2020
Related companies:  BIOZ, INC.

Rockwell Medical, Inc. Enters into Exclusive License and Supply Agreements with Sun Pharma for the Rights to Commercialize Triferic® in India

Read more ››
By: GlobenewsWire - 15 Jan 2020
Related companies:  Rockwell Medical, Inc.

ObsEva to Outline Corporate Plans For 2020 and Beyond at JP Morgan Healthcare Conference in San Francisco

Read more ››
By: GlobenewsWire - 15 Jan 2020
Related companies:  ObsEva SA

Nektar Issues Statement Regarding FDA Advisory Committee Vote for Oxycodegol

SAN FRANCISCO, Jan. 14, 2020 /PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) issued a statement today following a meeting of the Food and Drug Administration's (FDA's) Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) and Drug Safety and Risk Management Advisory Committee... Read more ››

By: PR Newswire Association LLC. - 15 Jan 2020
Related companies:  Nektar Therapeutics Inc.

Smartphone Solution Tackles Festering $25B Chronic Wound Problem

BOSTON, Jan. 15, 2020 /PRNewswire/ -- Healthy.io, the category creator of smartphone urinalysis and the global leader in turning smartphone cameras into clinical-grade medical devices, announced the launch of its second product line, a... Read more ››

By: PR Newswire Association LLC. - 15 Jan 2020

Europ Assistance opens new office in Thailand

BANGKOK, Jan. 15, 2020 /PRNewswire/ -- Europ Assistance today announced the opening of their new office in Bangkok, Thailand to provide its world-renowned travel and medical networks to the region and complete the presence of the Generali Group in Thailand. This is part of their overall plan... Read more ››

By: PR Newswire Association LLC. - 15 Jan 2020

Japanese Biosimilars Landscape Study, 2009-2020 - 25 Biosimilars of 12 Originator Products are Approved in Japan and Have Yielded Mixed Performances

DUBLIN, Jan. 14, 2020 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 15 Jan 2020

Chris Lehman Joins Avellino Labs As Chief Financial Officer

MENLO PARK, Calif., Jan. 14, 2020 /PRNewswire/ -- Avellino Labs, global biotechnology and precision medicine innovators, announced today that Chris Lehman has joined the company as Chief Financial Officer (CFO). Mr. Lehman brings to the role over twenty-five years of financial and transactional... Read more ››

By: PR Newswire Association LLC. - 15 Jan 2020
Related companies:  Avellino Labs

GenScript Biotech Global Forum Highlights Advances in Cell and Gene Therapy and Opportunities in China

SAN FRANCISCO, Jan. 14, 2020 /PRNewswire/ -- GenScript Biotech Corp., a leading global biotechnology group and a pioneer in the field of gene synthesis, today held its inaugural "Global Forum on Cell & Gene Therapy and the Booming China Market," during the JP Morgan Healthcare Conference... Read more ››

By: PR Newswire Association LLC. - 15 Jan 2020

New Small Molecule to Treat Alzheimer's Disease and Dravet Syndrome

SAN FRANCISCO, Jan. 14, 2020 /PRNewswire/ -- Gladstone researchers, in collaboration with Genentech, a member of the Roche group, have shown therapeutic efficacy of a new experimental drug in mouse models of Alzheimer's disease and a rare genetic form of epilepsy known as Dravet syndrome. The... Read more ››

By: PR Newswire Association LLC. - 15 Jan 2020

Eloxx Pharmaceuticals Provides Update on Progress of Its Phase 2 Clinical Programs for ELX-02 and ERSG Pipeline at Biotech Showcase™

Read more ››
By: GlobenewsWire - 14 Jan 2020
Related companies:  Eloxx Pharmaceuticals, Inc.
«  1  2  3  4  5  6  7  8  9 10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies